Profil
Paul Shin formerly worked at Avanir Pharmaceuticals, Inc., as Vice President-Research & Development Operations from 2011 to 2016, Intercept Pharmaceuticals, Inc., as Vice President-Global Clinical Operations from 2018 to 2020, Nestle Health Science SA, as SVP-Global Research & Development Operations from 2016 to 2018, and 89bio, Inc., as VP-Research & Development Operations from 2024 to 2025.
Mr. Shin received his undergraduate degree from the University of California.
Ehemalige bekannte Positionen von Paul Shin
| Unternehmen | Position | Ende |
|---|---|---|
| 89BIO, INC. | Geschäftsführer | 05.08.2024 |
| INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.08.2020 |
Nestle Health Science SA
Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Manufactures nutritional and supplement health products | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 |
| AVANIR PHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 |
Ausbildung von Paul Shin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Nestle Health Science SA
Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Manufactures nutritional and supplement health products | Health Technology |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
89bio, Inc.
89bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
















